Product Information
TURQOZ-28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3021 per EA under NDC 68180089513. Its NADAC has been published 146 times since Dec 20, 2023.
FDA first approved this application on Jul 31, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180089513
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202980FDA Approved
7/31/2023
TE Code
AB
On Market Since
11/29/2023
Price Statistics
The NADAC for TURQOZ-28 TABLET has been published 146 times since Dec 20, 2023, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3021 per EA |
|---|---|
| All-time high | $0.4077 (Apr 10, 2024) |
| All-time low | $0.2841 (Jul 22, 2026) |
| 52-week high | $0.3813 |
| 52-week low | $0.2841 |
| Median price | $0.3630 |
| Average price | $0.3525 |
| Largest weekly change | +27.0% (Aug 21, 2024) |
| Weeks tracked | 146 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the norgestrel and ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
norgestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TURQOZ-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TURQOZ-28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3021 per EA (NDC 68180089513), effective Sep 30, 2026.
How has the price of TURQOZ-28 TABLET changed over time?
Over the history we have for it, the NADAC for TURQOZ-28 TABLET has declined 21.0%. It has been tracked across 146 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for TURQOZ-28 TABLET?
Since Dec 20, 2023, the NADAC for TURQOZ-28 TABLET has ranged from a low of $0.2841 (Jul 22, 2026) to a high of $0.4077 (Apr 10, 2024), with a median of $0.3630 per EA.
Are there cheaper alternatives to TURQOZ-28 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TURQOZ-28 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TURQOZ-28 TABLET?
TURQOZ-28 TABLET (NDC 68180089513) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.